Patient recruitment is still the biggest challenge in clinical trials and Momentum is setting a world leading standard by leveraging years of experience in marketing and patient engagement strategies. The geographically diverse and dispersed locations of our sites give our partners an advantage in reaching a larger number of participants in a shorter period of time. By providing a seamless experience from engagement through to completion, we’ve built a comprehensive database of over 50,000 participants, enabling us to deliver high-quality study data as quickly and efficiently as possible.

Additionally, our Australian and New Zealand based teams are experienced in streamlined ethics processes, allowing for a fast-tracked approval time of four to six weeks.

For over 20 years, Momentum’s key personnel have worked alongside the most experienced investigators and researchers across Australia and New Zealand to successfully deliver more than 200 Phase Ib-IV clinical trials. Our facilities are equipped with the latest medical technology and all staff are proficient in the leading electronic case report forms and randomisation platform software. Momentum allocates a dedicated quality officer to all clinical trials, to ensure they comply with the International Council for Harmonisation (ICH) E6 Good Clinical Practice (GCP) and collect high quality and credible data. We take pride in upholding the highest clinical trial standards with our GCP trained teams and IATA certified staff.

Since 2001, we have demonstrated our commitment to innovation and quality, and our widespread presence across Australia and New Zealand makes us the only Trans-Tasman clinical research network. Momentum’s portfolio of 13 sites through the merging of P3 Research, AusTrials and Holdsworth House bring an unparalleled diversity of research experience and therapeutic capabilities. We can facilitate individual trials to be conducted across multiple sites, reducing the need for sponsors to co-ordinate numerous parties – resulting in a smoother trial process.

By partnering with Momentum, trial sponsors can expect a single point of contact from feasibility assessment through to trial completion. With our 48-hour initial response time, a dedicated team will provide consistent communication throughout the trial process, ensuring partners receive fast responses to enable timely decision-making and provide regular stakeholder updates. Our end-to-end support system allows for efficiency during the intricate clinical trial journey to ensure sponsors experience consistent, first-class care from the onset.